High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future

Overview

Journal J Clin Med

Specialty General Medicine

Date 2023 Apr 13

PMID 37048749

Authors

Claudia Crimi

Andrea Cortegiani

Affiliations

Soon will be listed here.

Abstract

High-flow nasal therapy (HFNT) was introduced into clinical practice in the early 2000s as a form of noninvasive respiratory support (NIRS) [...].

Citing Articles

Effects of high-flow nasal therapy on swallowing function: a scoping review.

Crimi C, Chiaramonte R, Vignera F, Vancheri C, Vecchio M, Gregoretti C ERJ Open Res. 2024; 10(4).

PMID: 38978547 PMC: 11228606. DOI: 10.1183/23120541.00075-2024.

Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension.

Pelaia C, Armentaro G, Lupia C, Maiorano A, Montenegro N, Miceli S J Clin Med. 2023; 12(17).

PMID: 37685538 PMC: 10488050. DOI: 10.3390/jcm12175472.

References

Cortegiani A, Crimi C, Sanfilippo F, Noto A, Di Falco D, Grasselli G . High flow nasal therapy in immunocompromised patients with acute respiratory failure: A systematic review and meta-analysis. J Crit Care. 2019; 50:250-256. DOI: 10.1016/j.jcrc.2018.12.015. View

Nagata K, Horie T, Chohnabayashi N, Jinta T, Tsugitomi R, Shiraki A . Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2022; 206(11):1326-1335. PMC: 9746854. DOI: 10.1164/rccm.202201-0199OC. View

Cortegiani A, Crimi C, Noto A, Helviz Y, Giarratano A, Gregoretti C . Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate. Crit Care. 2019; 23(1):201. PMC: 6549315. DOI: 10.1186/s13054-019-2473-y. View

Crimi C, Noto A, Cortegiani A, Campisi R, Heffler E, Gregoretti C . High Flow Nasal Therapy Use in Patients with Acute Exacerbation of COPD and Bronchiectasis: A Feasibility Study. COPD. 2020; 17(2):184-190. DOI: 10.1080/15412555.2020.1728736. View

Crimi C, Nolasco S, Campisi R, Nigro M, Impellizzeri P, Cortegiani A . Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study. J Clin Med. 2022; 11(24). PMC: 9782624. DOI: 10.3390/jcm11247323. View

Storgaard L, Hockey H, Laursen B, Weinreich U . Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018; 13:1195-1205. PMC: 5909797. DOI: 10.2147/COPD.S159666. View

Rochwerg B, Einav S, Chaudhuri D, Mancebo J, Mauri T, Helviz Y . The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020; 46(12):2226-2237. PMC: 7670292. DOI: 10.1007/s00134-020-06312-y. View

Ovtcharenko N, Ho E, Alhazzani W, Cortegiani A, Ergan B, Scala R . High-flow nasal cannula versus non-invasive ventilation for acute hypercapnic respiratory failure in adults: a systematic review and meta-analysis of randomized trials. Crit Care. 2022; 26(1):348. PMC: 9648030. DOI: 10.1186/s13054-022-04218-3. View

Crimi C, Pierucci P, Renda T, Pisani L, Carlucci A . High-Flow Nasal Cannula and COVID-19: A Clinical Review. Respir Care. 2021; 67(2):227-240. DOI: 10.4187/respcare.09056. View

10.

Oczkowski S, Ergan B, Bos L, Chatwin M, Ferrer M, Gregoretti C . ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J. 2021; 59(4). DOI: 10.1183/13993003.01574-2021. View

11.

Crimi C, Noto A, Madotto F, Ippolito M, Nolasco S, Campisi R . High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial. Thorax. 2022; 78(4):354-361. DOI: 10.1136/thoraxjnl-2022-218806. View

12.

Ospina-Tascon G, Calderon-Tapia L, Garcia A, Zarama V, Gomez-Alvarez F, Alvarez-Saa T . Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021; 326(21):2161-2171. PMC: 8652598. DOI: 10.1001/jama.2021.20714. View

13.

Goligher E, Slutsky A . Not Just Oxygen? Mechanisms of Benefit from High-Flow Nasal Cannula in Hypoxemic Respiratory Failure. Am J Respir Crit Care Med. 2017; 195(9):1128-1131. DOI: 10.1164/rccm.201701-0006ED. View

14.

Rea H, McAuley S, Jayaram L, Garrett J, Hockey H, Storey L . The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010; 104(4):525-33. DOI: 10.1016/j.rmed.2009.12.016. View

15.

Crimi C, Cortegiani A . Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease. J Comp Eff Res. 2021; 10(18):1317-1321. DOI: 10.2217/cer-2021-0220. View

16.

Kang B, Koh Y, Lim C, Huh J, Baek S, Han M . Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015; 41(4):623-32. DOI: 10.1007/s00134-015-3693-5. View

17.

Cortegiani A, Longhini F, Madotto F, Groff P, Scala R, Crimi C . High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care. 2020; 24(1):692. PMC: 7734463. DOI: 10.1186/s13054-020-03409-0. View

18.

Crimi C, Noto A, Cortegiani A, Impellizzeri P, Elliott M, Ambrosino N . Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections. Minerva Anestesiol. 2020; 86(11):1190-1204. DOI: 10.23736/S0375-9393.20.14785-0. View

19.

Perkins G, Ji C, Connolly B, Couper K, Lall R, Baillie J . Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial. JAMA. 2022; 327(6):546-558. PMC: 8787685. DOI: 10.1001/jama.2022.0028. View

20.

Longhini F, Pisani L, Lungu R, Comellini V, Bruni A, Garofalo E . High-Flow Oxygen Therapy After Noninvasive Ventilation Interruption in Patients Recovering From Hypercapnic Acute Respiratory Failure: A Physiological Crossover Trial. Crit Care Med. 2019; 47(6):e506-e511. DOI: 10.1097/CCM.0000000000003740. View